About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in San Diego | 14,679 Studies Near You | Clareo Health

Clinical Trials LocationsSan Diego

Clinical Trials in San Diego

Discover 14,679 clinical trials near San Diego, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 12981-13000 of 14,679 trials

COMPLETEDPhase 1/2< 1 mile

Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy

NCT00781001

The purpose of this study is to determine if vaporized cannabis is effective as an analgesic for the treatment of painful diabetic neuropathy.

Painful Diabetic Neuropathy

Center for Medicinal Cannabis Research17 participantsStarted Jul 2008

San Diego, California, United States

TERMINATEDPhase 4< 1 mile

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

NCT00206856

To determine the clinical utility of using the Triage® BNP Test to guide therapy in outpatients with heart failure

Abbott RDx Cardiometabolic720 participantsStarted Jul 2003

Scottsdale, Arizona, United States • San Diego, California, United States • San Francisco, California, United States +26 more locations

Find Trials by Condition in San Diego

Breast Cancerin San Diego Lung Cancerin San Diego Prostate Cancerin San Diego Colorectal Cancerin San Diego Melanomain San Diego Leukemiain San Diego Lymphomain San Diego Pancreatic Cancerin San Diego Ovarian Cancerin San Diego Brain Cancerin San Diego

Data from ClinicalTrials.govTerms

COMPLETEDPhase 2< 1 mile

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

NCT00394771

This is a 4-arm study to evaluate and compare bleeding patterns between three different doses of DR-1031 oral contraceptive with Seasonale oral contraceptive. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary

Breakthrough Bleeding

Duramed Research567 participantsStarted Oct 2006

Huntsville, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +47 more locations

COMPLETEDNA< 1 mile

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

NCT01907282

Preventing psychotic disorders such as schizophrenia and associated functional disability could relieve an enormous burden of personal and family suffering and economic losses to society. This project aims to conduct a pilot randomized trial to determine the efficacy of a family-focused treatment in comparison with treatment-as-usual in enhancing functional outcomes, stabilizing symptoms, and preventing or delaying the onset of full psychosis in transitional age youth with prodromal symptoms. The results of this study will be crucial for the development of cost-effective, evidence-based psychosocial approaches to psychosis prevention and thus will have major implications for public health.

University of California, Los Angeles129 participantsStarted Jan 2010

Los Angeles, California, United States • San Diego, California, United States • New Haven, Connecticut, United States +5 more locations

COMPLETEDNA< 1 mile

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

NCT00015691

The purpose of this study is to see whether metformin alone, rosiglitazone alone, or metformin and rosiglitazone together will lower insulin levels in the blood and decrease fat in the abdomen or other parts of the body. Studies have shown that certain anti-HIV medications can cause a number of side effects, including high blood sugar (resulting from the body's failure to use insulin), high insulin, and excess fat build-up in the abdominal area. These side effects are known to increase the risk of heart disease. Metformin and rosiglitazone are 2 drugs that have been shown to lower insulin resistance and lessen abdominal fat in patients who are not HIV-infected. This study will investigate the use of these drugs in HIV-infected patients.

HIV InfectionsLipodystrophyHyperinsulinemia

National Institute of Allergy and Infectious Diseases (NIAID)105 participants

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +31 more locations

COMPLETEDPhase 3< 1 mile

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

NCT00623428

This study will evaluate the efficacy and safety of peginterferon alfa-2a 40KD + ribavirin combination therapy given for 24 weeks versus 48 weeks in patients with chronic hepatitis C, genotype 2/3.

Hepatitis C, Chronic

Hoffmann-La Roche235 participantsStarted Jun 2008

Birmingham, Alabama, United States • La Jolla, California, United States • Lancaster, California, United States +98 more locations

COMPLETEDPhase 2< 1 mile

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

NCT00643760

The purpose of this study is to determine whether gabapentin enacarbil (XP13512/GSK1838262), hereafter referred to as GEn is effective in the treatment of neuropathic pain associated with diabetic peripheral neuropathy(DPN)

Neuropathy, Diabetic

XenoPort, Inc.421 participantsStarted Mar 2008

Alabaster, Alabama, United States • Birmingham, Alabama, United States • Dothan, Alabama, United States +87 more locations

COMPLETEDPhase 4< 1 mile

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

NCT00592839

This is a multi-center study to evaluate the effects of SCE-B on nocturnal vasomotor symptoms. Study duration will be approximately 16 weeks; this includes a 4-week screening period and approximately 5 scheduled clinic visits. Participants will receive one of two strengths of SCE-B tablets plus matching placebo or placebo only, and will have a physical and gynecological exams that may include transvaginal ultrasound, endometrial biopsy and a pap smear. Participants will be asked to wear a monitoring device for a portion of the study and be asked to complete a daily dairy.

Nocturnal Vasomotor Symptoms

Duramed Research157 participantsStarted Dec 2007

Anaheim, California, United States • Sacramento, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 3< 1 mile

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

NCT00236080

The purpose of the study is to compare the overnight efficacy and plasma concentration-time profiles of armodafinil and PROVIGIL, after multiple doses, in patients with excessive sleepiness associated with chronic Shift Work Sleep Disorder (SWSD).

Chronic Shift Work Sleep Disorder

Cephalon136 participantsStarted Aug 2005

Phoenix, Arizona, United States • Tucson, Arizona, United States • Hot Springs, Arkansas, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

NCT00078312

The primary objective of this study is to evaluate the safety and tolerability of Armodafinil (CEP-10953) administered on a flexible-dosage regimen of 100 to 250 mg/day for up to 12 months to patients with excessive sleepiness associated with a current diagnosis of narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS)(regular users of nasal continuous positive airway pressure \[nCPAP\] therapy), or chronic shift work sleep disorder (SWSD).

NarcolepsySleep Apnea, ObstructiveSleep Apnea Syndromes+1 more

Cephalon328 participantsStarted Jan 2004

Peoria, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +47 more locations

COMPLETED< 1 mile

Comparison of Aneuploidy Risk Evaluations

NCT01663350

This is a prospective, multi-center observational study designed to compare the test results of the Verinata Health Prenatal Aneuploidy Test to results of conventional prenatal screening for fetal chromosome abnormalities in 'all-risk' pregnancies.

PregnancyDown SyndromeEdwards Syndrome+2 more

Verinata Health, Inc.3,000 participantsStarted Jul 2012

San Diego, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +23 more locations

TERMINATEDPhase 3< 1 mile

4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma

NCT00634517

This 4-week clinical study evaluates the efficacy and safety of Albuterol Sulfate HFA Inhalation Aerosol in comparison with the Active Control, Proventil-HFA (3M Pharmaceuticals, Inc) in pediatric patients (4-11 years old) with mild-to-moderate asthma. In addition, pharmacokinetic profile in this population will be evaluated using a population PK approach with sparse blood samples.

Amphastar Pharmaceuticals, Inc.48 participantsStarted Mar 2008

Long Beach, California, United States • San Diego, California, United States • Stockton, California, United States +5 more locations

COMPLETEDPhase 16.9 miles

Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes

NCT01334151

The primary objective of this study is to assess the speed of absorption and onset of action of BIOD-105 and BIOD-107 and compare them to Humalog®.

Diabetes Mellitus Type 1

Biodel13 participantsStarted Mar 2011

Chula Vista, California, United States

COMPLETEDPhase 211 miles

NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00014677

RATIONALE: NBI-3001 may be able to locate cancer cells and stop them from growing. This may be an effective treatment for glioblastoma multiforme. PURPOSE: Randomized phase II trial to compare different regimens of NBI-3001 followed by surgery to remove the tumor in treating patients who have glioblastoma multiforme.

Brain and Central Nervous System Tumors

Neurocrine BiosciencesStarted Mar 2001

La Jolla, California, United States • Atlanta, Georgia, United States • St Louis, Missouri, United States +1 more locations

COMPLETEDPhase 294 miles

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

NCT01603069

This is a study where AZD3241 or placebo is given to patients with Parkinson's disease in a blinded and randomized assignment. The main objective is to see if safety and tolerability of the drug is acceptable.

Parkinson's Disease

AstraZeneca51 participantsStarted Oct 2012

Birmingham, Alabama, United States • Long Beach, California, United States • New Haven, Connecticut, United States +10 more locations

TERMINATEDPhase 2102 miles

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

NCT00557830

The primary objective of this study is to compare the effectiveness of a dose-escalation regimen (400 to 800mg bid) relative to the standard dosing regimen (400mg bid) of sorafenib given in patients with metastatic RCC. The secondary objectives are to evaluate the effects of the dose-escalation regimen on the quality of life (QoL) of patients with metastatic RCC and to characterize the safety and tolerability profile of a dose-escalation regimen of sorafenib in patients with metastatic RCC.

Renal Cell Carcinoma

Accelerated Community Oncology Research Network12 participantsStarted Jan 2008

Jonesboro, Arkansas, United States • La Verne, California, United States • Miami, Florida, United States +10 more locations

COMPLETEDPhase 3111 miles

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

NCT00336492

The purpose of the study is to evaluate the effectiveness and safety of infliximab (Remicade) in children with moderately to severely active ulcerative colitis.

Ulcerative Colitis

Centocor, Inc.60 participantsStarted Sep 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +24 more locations

COMPLETEDPhase 2111 miles

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

NCT00000925

The purpose of this study is to determine whether a high-quality protein food supplement will help HIV-positive patients maintain, and possibly gain, muscle mass. Many HIV-positive patients lose weight that they are then unable to regain. This may be because patients are not eating enough protein or are not eating the right kinds of protein. The protein eaten in foods (such as meat, eggs, or beans) may not be able to make up for the amount of protein lost due to HIV infection. This study gives patients high-quality protein food supplements to help them maintain and/or gain weight.

HIV InfectionsHIV Wasting Syndrome

National Institute of Allergy and Infectious Diseases (NIAID)56 participantsStarted May 1999

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +16 more locations

COMPLETEDPhase 2155 miles

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

NCT00617461

The purpose of this study is evaluate the difference between two doses of gabapentin enacarbil (XP13512/GSK1838262), hereafter referred to as GEn, on pain associated with post-herpetic neuralgia.

Neuralgia, Postherpetic

XenoPort, Inc.96 participantsStarted Mar 2008

Phoenix, Arizona, United States • Oxnard, California, United States • Roseville, California, United States +50 more locations

COMPLETEDPhase 2316 miles

Balloon REmodeling Antrostomy THErapy Study

NCT00645762

This study is designed to evaluate safety and effectiveness of a less invasive procedure to treat maxillary only, or maxillary and anterior ethmoid, chronic sinusitis. Additionally, this study will assess the feasibility of performing the procedure under local anesthesia.

Entellus Medical, Inc.71 participantsStarted Sep 2007

Fresno, California, United States • Evanston, Illinois, United States • Maywood, Illinois, United States +10 more locations

PreviousPage 650 of 734Next

Diabetes

in San Diego

Heart Diseasein San Diego